![Recombinant Human von Willebrand Factor (rVWF) Differs in Structure and Function from Plasma Derived Concentrates - ISTH Congress Abstracts Recombinant Human von Willebrand Factor (rVWF) Differs in Structure and Function from Plasma Derived Concentrates - ISTH Congress Abstracts](https://abstracts.isth.org/wp-content/uploads/2020/06/p_1120_1000016.jpg)
Recombinant Human von Willebrand Factor (rVWF) Differs in Structure and Function from Plasma Derived Concentrates - ISTH Congress Abstracts
![PDF) Efficacy and Safety of the Factor VIII/von Willebrand Factor Concentrate, Haemate-P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease PDF) Efficacy and Safety of the Factor VIII/von Willebrand Factor Concentrate, Haemate-P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease](https://i1.rgstatic.net/publication/11502412_Efficacy_and_Safety_of_the_Factor_VIIIvon_Willebrand_Factor_Concentrate_Haemate-PHumate-P_Ristocetin_Cofactor_Unit_Dosing_in_Patients_with_von_Willebrand_Disease/links/56849e4008ae051f9af04b30/largepreview.png)
PDF) Efficacy and Safety of the Factor VIII/von Willebrand Factor Concentrate, Haemate-P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease
Clinical use of Haemate® P in inherited von Willebrand's disease: a cohort study on 100 Italian patients | Haematologica
![HAEMATE P 2400 UI/1000 UI 1 VIAL POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION + 1 AMPOLLA DISOLVENTE - Farmacéuticos HAEMATE P 2400 UI/1000 UI 1 VIAL POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION + 1 AMPOLLA DISOLVENTE - Farmacéuticos](https://botplusweb.farmaceuticos.com/Documentos/AEMPS/Fotos/92943/full/56868_materialas.jpg)